If you have been reading about somatotroph and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2025-08-22. Numbers and descriptions here follow the published literature rather than marketing material.
冻干粉末一般在 -20°C 或更低温度、干燥避光条件下保存，可维持较长时间的稳定。复溶后稳定性明显下降，溶液中的肽链易发生水解、氧化与聚集，通常需冷藏并在短期内用完。反复冻融会加速聚集与降解，建议分装后单次使用。缓冲体系的 pH 与离子强度同样影响聚集速率，需要按具体实验条件验证。
研究用与临床用材料的标准并不相同。质量控制通常覆盖纯度、残留溶剂、反离子含量、微生物限度与内毒素水平，各项均有对应检测方法。随货文件应包含批号、检测项目、方法与结果，使数据可以追溯。核验时应关注纯度是否按主峰面积计算、杂质是否已定性、方法是否经过验证，这些信息决定结果能否被外部重复。
纯度与身份确认依赖色谱与质谱的组合。反相高效液相色谱在 214 nm 紫外检测下分离主峰与相关杂质，给出纯度百分比与保留时间；电喷雾或基质辅助激光解吸电离质谱提供分子量，用于确认 N 端修饰是否完整。序列层面可通过肽图或氨基酸分析验证。含量测定常用紫外吸收法或氮元素分析，不同方法之间需要做交叉校验。
Tesamorelin is a synthetic analog of growth hormone-releasing hormone, a peptide hormone produced by the hypothalamus. The molecule retains the 44-amino-acid sequence of human GHRH and carries a trans-3-hexenoyl modification at its N-terminus. This modification increases resistance to enzymatic degradation and extends the peptide's functional stability relative to native GHRH. The compound is supplied as a lyophilized powder for reconstitution and subcutaneous administration in clinical settings. Its development code was TH9507, and it belongs to the GHRH analog class. It is not a growth hormone product; instead, it acts upstream to stimulate endogenous growth hormone release.
Clinical interest in tesamorelin arose from the need to address visceral adiposity in people living with HIV. Antiretroviral therapy improved survival but was associated in some patients with central fat accumulation, altered lipid profiles, and metabolic complications. This condition, often called HIV-associated lipodystrophy, involves excess visceral adipose tissue that is difficult to manage through diet and exercise alone. Investigators evaluated tesamorelin because GHRH analogs can stimulate growth hormone secretion and influence fat distribution without direct liposuction or invasive procedures.
| 性质 | 取值 | 备注 |
|---|---|---|
| 外观 | 白色至类白色冻干粉 | 常见形态 |
| 溶解性 | 易溶于水与水性缓冲液 | 多肽类通性 |
| 典型储存温度 | -20°C 或更低 | 干燥避光 |
| 常用纯度方法 | 反相高效液相色谱 | 214 nm 紫外检测 |
| 常用分子量确认 | 质谱 | 电喷雾或激光解吸 |
Identity and purity are judged through a combination of chromatographic and mass spectrometric techniques. Reversed-phase high-performance liquid chromatography separates the intact peptide from truncated, oxidized, and deamidated variants, and the resulting peak-area percentages yield a purity figure. Electrospray ionization mass spectrometry confirms the expected molecular mass and can expose unanticipated modifications. Amino acid analysis and peptide mapping support sequence fidelity, while water content, pH, sterility, and bacterial endotoxin testing describe the physical and microbiological attributes of a finished lot.
Regulatory position depends on jurisdiction and on the form in which the material is sold. A branded product holds approval in the United States for a defined indication, and prescribing is confined to that label. Material marketed for laboratory research is not evaluated for human use and carries no such clearance. Independent verification therefore rests on certificates of analysis, third-party testing, and documented chain of custody. The substance also appears on the World Anti-Doping Agency prohibited list within the category covering growth hormone-releasing factors.
Lyophilized material is typically held under refrigeration between two and eight degrees Celsius, shielded from light and ambient moisture. Peptides of this size adsorb to glass and plastic, so working procedures often call for low-binding containers and as few transfers as possible. Absorbed water during weighing shifts the apparent mass of a sample, and controlling room humidity reduces that source of error. Once dissolved, solutions are kept cold and used within the interval printed on the accompanying label or certificate. Degradation accelerates markedly in dilute aqueous form.
Interest in this peptide developed because native GHRH has a short circulating lifetime. The N-terminal modification slows cleavage by dipeptidyl peptidase IV, an enzyme that removes the first two residues of many peptides and terminates their activity. Slower degradation means a longer window of receptor stimulation per administration. This design logic parallels other modified peptide hormones, where a small chemical change at a vulnerable site yields a more durable molecule without altering the core mechanism of action.
The peptide is synthesized chemically rather than extracted from biological sources. Solid-phase synthesis builds the chain from the C-terminus toward the N-terminus, after which the hexenoyl group is attached. Purity is typically assessed by high-performance liquid chromatography, and identity is confirmed by mass spectrometry. Regulatory review of the finished product focuses on these analytical controls, since small deviations in sequence or modification can change biological activity. Questions about long-term effects on the pituitary axis remain areas of continued investigation.
Tesamorelin is a synthetic peptide that belongs to the growth hormone-releasing hormone (GHRH) family. Its sequence corresponds to the fully active 44-amino-acid form of human GHRH, with a single structural modification: the addition of a trans-3-hexenoyl group at the N-terminus. That modification is not found in the naturally occurring hormone and was introduced deliberately during development to improve stability against enzymatic degradation. The compound is therefore best described as a stabilized analogue rather than a naturally occurring peptide.
Tesamorelin acts on the growth hormone-releasing hormone receptor, a G-protein-coupled receptor found on somatotroph cells in the anterior pituitary. Binding triggers a rise in intracellular cyclic AMP, which in turn opens ion channels and raises calcium concentrations, leading to release of stored growth hormone into the bloodstream. Because the peptide works through the same receptor as the body's own GHRH, the resulting secretion follows a pulsatile pattern rather than a continuous elevation. The N-terminal modification slows enzymatic breakdown, so the signal persists longer than it would with the unmodified hormone.
Growth hormone released from the pituitary stimulates the liver and other tissues to produce insulin-like growth factor 1, a stable circulating protein that serves as a practical marker of activity. Clinical studies therefore track IGF-1 concentrations alongside the hormone itself, and they commonly measure body composition with imaging rather than relying on body weight alone. Visceral adipose tissue, the fat surrounding abdominal organs, is quantified by computed tomography in the studies that supported approval. Adverse effects reported in trials include injection-site reactions, joint pain, and increases in blood glucose, which is why monitoring accompanies use.
Questions remain about how much of the observed fat reduction reflects direct GHRH-receptor signaling versus the downstream growth hormone and IGF-1 surge. It is also unclear whether the compound produces meaningful benefit in populations without lipodystrophy, since trials in cognitive impairment did not reach their stated goals. Long-term effects on glucose metabolism and on cardiovascular outcomes are not fully characterized. Published work generally describes effects on surrogate markers rather than on hard clinical endpoints, and independent replication of some findings is limited.
Receptor-level activity begins when the peptide binds the GHRH receptor, a class B G-protein-coupled receptor found on pituitary somatotroph cells. Occupancy triggers Gs-mediated activation of adenylyl cyclase and a rise in intracellular cyclic AMP, which in turn promotes synthesis and pulsatile release of growth hormone. Because the compound acts upstream of the growth hormone axis rather than supplying hormone directly, its effect depends on intact pituitary function. Binding studies in cell culture and animal models have established this pathway; the detailed kinetics of receptor recycling in humans remain less well characterized.
Physicochemical behavior is dominated by the peptide backbone. The molecule is hydrophilic and carries a net positive charge near neutral pH, owing to several arginine and lysine residues. In solution it adopts a largely unstructured conformation, and aggregation is a known concern for peptide products of this size. Oxidation of methionine and deamidation of asparagine or glutamine residues are the principal chemical degradation routes. These liabilities shape how the material is formulated, handled, and analyzed, and they explain why lyophilized presentations are common in research settings.
== Intein == An intein is a segment of a protein that is able to excise itself and join the remaining portions (the exteins) with a peptide bond during protein splicing. Inteins have also been called protein introns, by analogy with (RNA) introns.
=== Laboratory synthesis === The chemical synthesis of psilocybin has been described. Albert Hofmann and colleagues first synthesized psilocybin in 1958. Since then, various chemists have improved the methods for laboratory synthesis and purification of psilocybin. In particular, Shirota and colleagues reported a novel method in 2003 for the synthesis of psilocybin at the gram scale from 4-hydroxyindole that does not require chromatographic purification. Fricke and colleagues described an enzymatic pathway for the synthesis of psilocybin and psilocin, publishing their results in 2017. Sherwood and colleagues significantly improved upon Shirota's method (producing at the kilogram scale while employing less expensive reagents), publishing their results in 2020.
==== Pharmacological significance ==== ACE is a pharmaceutical target of ACE inhibitor drugs, which decrease the rate of conversion of angiotensin I to angiotensin II, and of angiotensin II receptor antagonists which block angiotensin II AT1 receptors. Angiotensin II results in increased inotropy, chronotropy, catecholamine and sensitivity, aldosterone levels, vasopressin levels, and cardiac remodeling and vasoconstriction through AT1 receptors on peripheral vessels (conversely, AT2 receptors impair cardiac remodeling). This is why ACE inhibitors and ARBs help to prevent remodeling that occurs secondary to angiotensin II and are beneficial in congestive heart failure.
Sources: en.wikipedia.org
== Role in disease == A defect in the degradation of glucocerebrosides is Gaucher's disease. The corresponding defects for galactocerebrosides are: a) Ceramide trihexoside (globotriaosylceramide) accumulation – Fabry's disease. Clinical features include acroparaesthesia (tingling, pins and needles sensation in the extremities) b) Galactocerebroside (galactosylceramidase) accumulation – Krabbe disease.
===== InSight Crime analysis ===== The "40" in the message is a reference to Miguel Treviño Morales, a top leader of Los Zetas based in Nuevo Laredo, and longtime adversary of Joaquín Guzmán. The "H" is presumably Héctor Beltrán Leyva, the last remaining brother of the Beltrán Leyva Cartel. The Beltrán Leyva organization, unlike the Zetas, has presence in Sinaloa state, and would probably have an easier time attacking the Sinaloa Cartel on its own turf. The message does not mention the fact that the Gulf Cartel is probably supporting the Sinaloa Cartel in carrying out the executions. In addition, the banner suggests that the alliance between Los Zetas and the Beltrán Leyva Cartel remains intact as of 2012 despite the losses it lived in 2008. The message also suggests the differences in the modus operandi of Los Zetas and the Sinaloa Cartel, because as authors of InSight Crime allege, the Zetas have a reputation of operating through extortion, kidnappings, robberies, and other illicit activities; in contrast, the Sinaloa Cartel is known simply for drug trafficking. (Both assertions are not wholly true, but often reflect a popular sentiment.) Guzmán attempted to take over Nuevo Laredo after the capture of the Gulf Cartel leader, Osiel Cárdenas Guillén, in 2003. Nevertheless, Guzmán retreated after a few years of bloody turf wars. The Sinaloa Cartel's return to Nuevo Laredo, however, was seen again in March 2012 after Guzmán reportedly left several corpses and a message heralding his return.
== Funding and infrastructure == Initial construction costs were covered by the ERDF and Czech state funds. Operational funding comes from competitive grants, including Czech Science Foundation (GACR) awards and Horizon Europe projects. The campus features a cogeneration plant and rainwater recycling systems.
Martin Fleischmann of the University of Southampton and Stanley Pons of the University of Utah hypothesized that the high compression ratio and mobility of deuterium that could be achieved within palladium metal using electrolysis might result in nuclear fusion. To investigate, they conducted electrolysis experiments using a palladium cathode and heavy water within a calorimeter, an insulated vessel designed to measure process heat. Current was applied continuously for many weeks, with the heavy water being renewed at intervals. Some deuterium was thought to be accumulating within the cathode, but most was allowed to bubble out of the cell, joining oxygen produced at the anode. For most of the time, the power input to the cell was equal to the calculated power leaving the cell within measurement accuracy, and the cell temperature was stable at around 30 °C. But then, at some point (in some of the experiments), the temperature rose suddenly to about 50 °C without changes in the input power. These high temperature phases would last for two days or more and would repeat several times in any given experiment once they had occurred. The calculated power leaving the cell was significantly higher than the input power during these high temperature phases. Eventually the high temperature phases would no longer occur within a particular cell. In 1988, Fleischmann and Pons applied to the United States Department of Energy for funding towards a larger series of experiments. Up to this point they had been funding their experiments using a small device built with $100,000 out-of-pocket.
Sources: en.wikipedia.org
== Other studies == Lung cancer - Life Length is working on developing an algorithm to detect patients at risk for lung cancer. With its telomere measurement platform, the test could potentially fill the gap in lung cancer screening techniques in a routine, minimally invasive, and low-cost way. Life Length was the European Seal of Excellence by the European Commission for its project proposal in lung cancer research. Childhood cancer - Life Length has conducted the largest childhood cancer research project to date, obtaining samples from about 100 children with cancer and healthy children. The aim of the study was to help oncology and hematology specialists make better decisions and increase the chances of these children beating cancer. Life Length has carried out these studies with the support of one of the most important children's hospitals in Spain, the Hospital Infantil Universitario Niño Jesús.
== Other uses == "Sip", a song from Joeboy Stranka Ivana Pernara, a Croatian political party Shelter-in-place, an emergency procedure Sip (kinship) Sip or Zip, one of the 18 months of the Haab', a part of the Maya calendric system SIP Grenade, self igniting phosphorus The Society of International Photographers, a not-for-profit organization founded in 1936 Soviet Interview Project, a research project conducted in the early 1980s Strangers in Paradise, an award-winning comic book State Implementation Plan, a United States state plan for complying with the federal Clean Air Act Sub-irrigated planter, a type of gardening container Sip as in SipSipStefan "Sip", a 2017 song by Chris Brown from Heartbreak on a Full Moon
=== Available forms === Propoxyphene was initially introduced as propoxyphene hydrochloride. Shortly before the patent on propoxyphene expired, propoxyphene napsylate form was introduced to the market. The napsylate salt (the salt of naphthalene-2-sulfonic acid) is claimed to be less prone to non-medical use, because it is almost insoluble in water, so cannot be used for injection. Napsylate also gives lower peak blood level. Because of different molar mass, a dose of 100 mg of propoxyphene napsylate is required to supply an amount of propoxyphene equivalent to that present in 65 mg of propoxyphene hydrochloride. Before the FDA-directed recall, dextropropoxyphene HCl was available in the United States as a prescription formulation combined with paracetamol (acetaminophen) in ratio from 30 mg / 600 mg to 100 mg / 650 mg (or 100 mg / 325 mg in the case of Balacet), respectively, usually named Darvocet. In Australia, dextropropoxyphene is available on prescription, both as a combined product (32.5 mg dextropropoxyphene per 325 mg paracetamol branded as Di-gesic, Capadex, or Paradex; it is also available in pure form (100 mg capsules) known as Doloxene, however its use has been restricted.
Sources: en.wikipedia.org
多肽在反相柱上按疏水性差异分离，能有效区分主峰、缺失序列片段与氧化产物。配合紫外检测可获得可量化的纯度百分比，是肽类分析的常规手段。
一般建议密封、避光、干燥，并在 -20°C 或更低温度下存放。温度波动和湿气是主要风险，长期存放应避免反复开启容器。
没有统一答案，取决于缓冲液、浓度、pH 与储存温度。多数做法是冷藏并在数天至数周内用完，具体期限需要通过稳定性实验确认。
It is a synthetic peptide analog of human growth hormone-releasing hormone. It is used clinically to reduce excess visceral abdominal fat in adults with HIV-associated lipodystrophy. It works by stimulating pituitary growth hormone release.